Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

Sep 9, 2019

30786_dirs_2019-09-09_757e1228-3360-4491-9656-4d58c37bc104.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-05

Reporting Person: TUMOLO ANNETTE (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-05 Bio-Rad A Common Stock M 600 Acquired 2496.3476 Direct
2019-09-05 Bio-Rad A Common Stock F 208 $339.48 Disposed 2288.3476 Direct
2019-09-06 Bio-Rad A Common Stock S 371 $340.00 Disposed 1917.3476 Direct
2019-09-07 Bio-Rad A Common Stock M 600 Acquired 2517.3476 Direct
2019-09-07 Bio-Rad A Common Stock F 208 $335.59 Disposed 2309.3476 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-05 Restricted Stock Units $0 M 600 Disposed Bio-Rad A Common Stock (600) Direct
2019-09-07 Restricted Stock Units $0 M 600 Disposed Bio-Rad A Common Stock (600) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 5, 2018.

F4: The restricted stock units vest in five equal annual installments beginning September 7, 2017.